Study Will Provide Cash Payments To Encourage People With Chronic Diseases To Take Medications
Main Category: ComplianceAlso Included In: Public Health; IT / Internet / E-mail; Pharmacy / Pharmacist
Article Date: 25 Jun 2008 - 9:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Hartford Courant on Sunday examined a new lottery-like program that offers patients a chance at winning daily cash prizes of $10 or $100 if they promptly take their prescription medications.
According to the Courant, the lottery program -- part of a $40,000 study developed by the University of Pennsylvania's School of Medicine and the Aetna Foundation -- is "an unusual and fun way of getting at a huge problem -- failure of people with chronic conditions to take medications as prescribed." According to the Courant, patients' failure to take medications on schedule can have "dire and costly consequences for people's health and the nation's strained health care system."
For the study, Stephen Kimmel -- director of cardiovascular epidemiology and associate professor of medicine and epidemiology at Penn -- and Kevin Volpp, the key investigators in the study, will enroll 100 adult patients and observe them for 180 days. Each patient will be given a "Med-eMonitor," a device that is electronically linked to a medication database and programmed remotely via the Internet. While the device's reminder mechanism will not be activated for the duration of the study, it will ask patients to indicate when they are taking their pills, so that they will be entered into the daily drawing for the cash prize.
Only 50 of the 100 participants will be eligible for the drawings, while the remaining 50 patients will be the control group. More than half of the 100 patients already have been enrolled in the study, which will focus on patients who take warfarin, a blood-thinning drug to prevent stroke that is commonly sold under the brand name Coumadin.
Kimmel said he believes other drugs that require careful, consistent use also would lend themselves to a lottery approach, such as certain anti-epileptic drugs, medications to prevent rejection of transplanted organs and HIV/AIDS drugs. Kimmel said that after the warfarin study concludes, "then we have to have a discussion about whether and when it's appropriate to use (a lottery), if at all."
Extent, Implications, Debate
According to the World Health Organization, various reports indicate that only about 50% of patients with serious ailments in developed countries take their medications as prescribed. In addition, about 125,000 people in the U.S. die annually from illnesses that can be treated because they fail to take their medications as instructed, according to a study published in the Journal of Applied Research.
The study also stated that about $8.5 billion in incurred costs at U.S. hospitals can be attributed to the failure of patients to take their medications properly. According to the Courant, a "lively debate is likely" regarding the program.
Shannon Kampa, a principal and director of pharmacy for Mercer, said that, if employers used the program, they would have to consider whether it is fair because it could seem as if employees are being rewarded for being ill. In addition, the lottery could be viewed "as a bribe to people who should have taken more initiative on their own to protect or improve their health," the Courant reports (Levick, Hartford Courant, 6/22).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our compliance section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/112662.php>
APA
http://www.medicalnewstoday.com/releases/112662.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



